Related Experiment Video

Updated: May 20, 2026

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer
09:40

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

Ovarian cancer: emerging molecular-targeted therapies

Carole Sourbier1

  • 1Rockville, MD, USA.

Biologics : Targets & Therapy
|July 19, 2012
PubMed

Insights

New molecular targets offer hope for ovarian cancer patients. Understanding these targets can improve personalized therapies for this aggressive disease, potentially increasing cure rates beyond the current 30%.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Ovarian cancer is an aggressive and heterogeneous disease with high mortality.
  • Current treatments like chemotherapy are often ineffective for recurrent disease, with only 30% cure rates.
  • Advances in understanding molecular mechanisms are paving the way for new therapeutic strategies.

Purpose of the Study:

  • To review the rationale behind molecular-targeted therapies for ovarian cancer.
  • To examine newly identified molecular targets for personalized treatment approaches.
  • To discuss the potential of these targets to improve patient outcomes.

Main Methods:

  • Literature review of recent studies on ovarian cancer molecular mechanisms.
  • Analysis of emerging molecular targets and their therapeutic implications.
  • Discussion of personalized medicine strategies in ovarian cancer treatment.

Main Results:

  • Identification of key molecular pathways driving ovarian cancer progression.
  • Emergence of novel molecular-targeted agents showing promise in preclinical and clinical studies.
  • Potential for tailored therapies based on individual tumor molecular profiles.

Conclusions:

  • Molecular-targeted therapies represent a significant advancement in ovarian cancer treatment.
  • Personalized medicine approaches utilizing identified molecular targets can enhance treatment efficacy.
  • Further research into molecular targets is crucial for improving survival rates in ovarian cancer patients.
Keywords:
BRCAPI3K/Aktangiogenesismetabolismovarian cancer

More Related Videos

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence08:55

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence

Published on: November 2, 2014

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...